Researcher.Life Logo

Journal of Pharmacology and Experimental Therapeutics : Impact Factor & More

eISSN: 1521-0103pISSN: 0022-3565

Key Metrics

CiteScore
7.1
Impact Factor
< 5
SNIP
1.04
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Pharmacology and Experimental Therapeutics

Journal of Pharmacology and Experimental Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1909
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Pharmacology and Experimental Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Pharmacology and Experimental Therapeutics

Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a.
  • 1 May 2026
  • The Journal of pharmacology and experimental therapeutics
Tear Film Proteome Signatures of Acute Ocular Injury Following Vesicant Exposure (Abstract ID: 230253)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Sex Differences in the Repeated Co-Exposure of Nicotine and Ethanol Vapor on Central Amygdala Neuronal Activity in C57BL/6J Mice (Abstract ID: 226032)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Neurotoxic Methamphetamine Exposure Alters Mitochondrial Morphology in Ventral Tegmental Area Dopaminergic Neurons (Abstract ID: 231899)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
  • 28 Jan 2027
  • The Journal of pharmacology and experimental therapeutics
Multitarget microRNA sponge for pancreatic ductal adenocarcinoma: Simultaneous targeting of miR-21, miR-155, and miR-18a.
  • 1 May 2026
  • The Journal of pharmacology and experimental therapeutics
Tear Film Proteome Signatures of Acute Ocular Injury Following Vesicant Exposure (Abstract ID: 230253)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Sex Differences in the Repeated Co-Exposure of Nicotine and Ethanol Vapor on Central Amygdala Neuronal Activity in C57BL/6J Mice (Abstract ID: 226032)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Neurotoxic Methamphetamine Exposure Alters Mitochondrial Morphology in Ventral Tegmental Area Dopaminergic Neurons (Abstract ID: 231899)
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics
Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist
  • 1 May 2026
  • The Journal of Pharmacology and Experimental Therapeutics

FAQs on Journal of Pharmacology and Experimental Therapeutics